Insys catapulted from penny-stock status to a $3 billion corporation in just a couple of years. The company has more than 500 employees nationally, including 250 or so in Arizona.

Outlook How opioid maker Insys brazenly flouted the law February 4, 2022 More than 3 years ago ...

Insys Therapeutics' former top brass owes a collective $48.3 million in restitution for its role in the U.S. opioid crisis, a federal court in Boston ruled this month.

Insys, based in Chandler, Arizona, filed for bankruptcy protection in 2019. A lower court judge had set aside some of the jury’s findings, but the 1st Circuit restored the original verdicts. The ...

Shares from opioid maker Insys Therapeutics Inc. will be delisted from the Nasdaq on June 19, the company said in a government filing on Tuesday. The news follows the company's Chapter 11 ...

On Monday, Insys Therapeutics filed for Chapter 11 bankruptcy protection while it sells off its assets after reaching a US$225 million settlement with the justice department last week over fraud ...

Insys Therapeutics filed for Chapter 11 on Monday, just five days after it agreed to pay $225 million to settle a Justice Department probe into bribes it paid doctors to get them to prescribe its ...

Insys announced in November that it was reviewing “strategic alternatives” to sell or license its fentanyl spray Subsys, and last quarter quarter Insys said that it had hired Lazard Frères ...

As of Dec. 31, Insys had 226 full-time employees. The company reported a 2018 net loss of $124.3 million, or $1.68 a share, on revenue of $82.1 million, after a loss of $227.0 million, or $3.12 a ...

Drugmaker Insys Therapeutics Inc filed for bankruptcy protection on Monday amid mounting expenses driven by a U.S. Justice Department probe into claims it paid doctors bribes to prescribe a ...

Insys warned investors in May that its legal costs could lead it to file for bankruptcy protection. The company’s stock has fallen to 60 cents Monday morning from about $7 one year ago.

Pharmaceutical company Insys Therapeutics filed for Chapter 11 bankruptcy protection Monday less than a week after pleading guilty to federal fraud charges and agreeing to pay $225 million to ...